Overview

A Study to Assess Objective Endpoint Measurements of Response in Bacterial Skin Infections

Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare clinical response to the measurement techniques of several objective measures of clinical efficacy for use in future ABSSSI (Acute Bacterial Skin and Skin Structure Infection) clinical trials
Phase:
Phase 2
Details
Lead Sponsor:
Melinta Therapeutics, Inc.
Treatments:
Fluoroquinolones
Linezolid
Vancomycin